0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
- RxCUI
- 861366
- RxNorm name
- 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
- Display name
- 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
- Full name
- 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arixtra | FONDAPARINUX SODIUM | Mylan Institutional LLC | d3b30c68-cf45-4b46-8ba6-72090f7ba01a | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 861366 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d3b30c68-cf45-4b46-8ba6-72090f7ba01a | Arixtra 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra] [SBD] · 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe [SY] · Arixtra 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 4 | 13 | These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous use Initial U.S. Approval: 2001 | 20241210 |
| ec235119-cb58-4939-942c-11d3923d289f | Arixtra 7.5 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra] [SBD] · 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe [SY] · Arixtra 7.5 MG per 0.6 ML Prefilled Syringe [SY] | 4 | 1 | These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium) Solution for subcutaneous injection Initial U.S. Approval: 2001 | 20120123 |